Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

1. Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer

   Hanyue Ma, Lysanne D. A. N. de Muynck, Ruben D. Houvast +7

   МақолаPeptidase Inhibition and AnalysisBioconjugate Chemistry20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.002376

2. Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis

   Michael C. Frey, Victor Lopez-Lopez, Alessia Benz +12

   МақолаPancreatic and Hepatic Oncology ResearchAnnals of Surgical Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000452